SUMMARY Ten patients with follicular lymphoma presented with a high white cell count (45-220 x 109/1) which resembled chronic lymphocytic leukaemia (CCL): all had pronounced splenomegaly and, except one, generalised lymphadenopathy. The blood lymphocytes were small with scanty cytoplasm, densely condensed nuclear chromatin, and deep clefts originating in sharp angles from the nuclear surface. CLL cells are larger, have more cytoplasm, a different pattern of chromatin condensation, and may have shallow nuclear indentations or foldings rather than clefts. The circulating follicular lymphoma cells had moderate to strong membrane immunoglobulins (SmIg), low mouse (M)-rosettes, strong reactivity with the monoclonal antibody FMC7, and occasional expression of the CD5-antigen; at least one third of cells in each case were positive with anti-cALLa (J5,CD10). Half the cases were referred as B-CLL but none had the typical B-CLL immunophenotype: weak SmIg, M-rosettes of > 50%, CD5 positive, FMC7 and J5 negative. The diagnosis of follicular lymphoma was confirmed by lymph node biopsy in seven of the 10 cases. The overall response to treatment was poor and five patients died within three years of diagnosis. This aggressive form of follicular lymphoma needs to be distinguished from B-CLL as different management is required.
Follicular lymphoma is the most common type of nonHodgkin's lymphoma (NHL) . In the working formulation the agreed designations within the group of low grade NHL are malignant lymphoma, follicular, predominantly small cleaved cell, or mixed small cleaved and large cell.' Follicular lymphoma cells originate in the germinal centres of lymph nodes and consist of both small cleft lymphocytes or centrocytes and large blasts or centroblasts, with predominance of the former.2 Thus in the Kiel classification this tumour is designated centroblastic/centrocytic lymphoma. This lymphoma may evolve to or, more rarely, present in a leukemic phase, and the incidence of such an event varies in different series, ranging from 4.5%2 to 23%.3 In the leukaemic form of follicular lymphoma a variable proportion of the peripheral blood lymphocytes exhibit characteristic morphological detail which has been described as "notched-nucleus cell". 4 The degree of lymphocytosis at presentation is also variable, but rarely exceeds 30 x 109/1.3 5 Accepted for publication 7 April 1988 Over the past five years we assembled a series of 10 patients with an aggressive form of follicular lymphoma, with advanced clinical features at presentation, and in a leukaemic phase with high white cell counts. In this unusual form of presentation follicular lymphoma can often be mistaken for chronic lymphocytic leukemia (CLL). In this report we describe the features of the disease in patients with follicular lymphoma, with special emphasis on the morphological and immunological characteristics that can help in the differential diagnosis of CLL and other B cell leukaemias.
Patients and methods
Ten patients with follicular lymphoma in leukaemic phase and white cell counts greater than 40 x 109/l were included in this study. Clinical and haematological features selected for analysis comprised sex, age, haemoglobin concentration, platelet count, white cell count, size of palpable liver and spleen and degree of lymph node enlargement, either at presentation or at onset of leukaemic phase, or both. Treatment The peripheral blood lymphocytes had a characteristic morphology at light microscopical examination (figs 1 and 2). They were very small with diameters comparable with those of erythrocytes, they had a regular round shape, and little or no heterogeneity in size in most cases. The cytoplasm was scanty and, when visible, consisted ofa thin rim confined to between one fourth and one half of the cell circumference; a 953 variable, usually large, proportion of lymphocytes seemed to be devoid of any cytoplasm. The nucleus was also characteristic: the chromatin was homogeneously and heavily condensed and nucleoli were seldom seen. The most distinct feature of these lymphocytes was a pattern of nuclear irregularity represented by the presence ofone or two, rarely three, deep clefts, originating from the nuclear surface in sharp angles, and being recognised as very thin lines 5 showing slightly larger cells than infig I but with homogeneously stained chromatin and distinct nuclear clefts which seem to divide nuclei of some cells in half crossing the chromatin, sometimes appearing to divide the nucleus in two parts (figs I and 2). The proportion of small lymphocytes with cleft nuclei varied from less than 10% to as high as 88%, being greater than 30% in seven of the 10 cases. In addition to small lymphocytes, a minor population ( < 10%) of large blastic cells with loose chromatin and multiple nucleoli, occasionally with nuclear clefts, was seen in all cases. "Smudge" cells, commonly observed in CLL, were either absent or scanty.
At ultrastructural level ( fig 3) the lymphocytes were very small with a very high nuclear to cytoplasmic ratio (N:C). The Golgi region was inconspicuous and Melo, Robinson, Oliveira, Thompson, Lanpert, Ng, Galton, Catovsky showed a much lesser degree ofdisease, with preservation of fat spaces, but a similar paratrabecular and diffuse pattern. Case 10 also showed occasional apparently intramedullary aggregates, and case 2 showed intramedullary aggregates, and a diffg,se pattern with no definite paratrabecular infiltrate The cytology of the marrow infiltrates was similar tb that of the lymph nodes-that is, small cleaved cells predominated.
TREATMENT AND FOLLOW UP Each patient in this series was treated by the referring physician and therefore the therapeutic regimens varied. Five patients were dead at the time of this report and four were reported to be alive at the closing date for this analysis; one was lost to follow up. Five patients survived less than three years from diagnosis. One (case 2) died within 24 hours of diagnosis; two others (cases 4 and 7) did not respond to treatment and died one and five months after presentation. Two patients (cases I and 3) had a partial remission but relapsed within one and a half years; they survived 31 and 35 months, respectively.
Five patients achieved a complete remission with combination chemotherapy. Two of them (cases 5 and 9) relapsed eight months after treatment was discontinued. Case 5 had a new complete remission continuing 15 months from diagnosis and case 9 is alive with active disease 29 months after clinical presentation. Cases 6 and 8 had complete remission which persisted for 10 months but case 6 was lost to follow up. Case 10 had a complete remission which lasted 16 months. A partial response was subsequently achieved but a leukaemic phase evolved four years from diagnosis and this responded partially. He is alive with persistent disease 57 months from diagnosis and six months after the leukaemic phase had become apparent. 
Discussion
The diagnosis of lymphoma in a patient with a high white cell count is rarely considered if the circulating cells resemble, at first sight, the small mature looking lymphocytes of CLL. In fact, half the patients in the present series and several others in Spiro's survey3 had been referred as cases ofCLL, and the diagnosis would have been accepted if lymph node biopsy and marker studies had not been carried out.
Several features suggest follicular lymphoma rather than CLL in cases with high white cell counts. The mean age of incidence of follicular lymphoma is at least 10 years below that for CLL (54 (11) v 67 (8) respectively, in the present series) and, as pointed out previously,3 lymph node biopsy is always necessary in patients below age 40, when CLL is uncommon. The sex ratio in some series of follicular lymphoma has shown an excess of women,3 though in our small series the male:female ratio (2-3:1) resembled that of large CLL series. 8 10 The clinical features of patients with follicular lymphoma in leukaemic phase are similar to those of CLL, but the massive lymph node enlargement seems to be more conspicuous in follicular lymphoma. On the other hand, all our patients with follicular lymphoma had clinically important splenomegaly, and this perhaps suggests that this diagnosis would seem unlikely in patients with a high white cell count who do not have an enlarged spleen.
The lymphocyte morphology in well prepared peripheral blood films is important in distinguishing CLL from follicular lymphoma with high white cell count. The circulating neoplastic cells in follicular lymphoma and in CLL can be recognised as distinct morphological types on the basis of a combination of features (table 2) . The very small size, the scarcity of visible cytoplasm, and the highly condensed nuclear 958 Melo, Robinson, Oliveira, Thompson, Lampert, Ng, Galton, Catovsky chromatin divided by thin lines or clefts originating in sharp angles from the nuclear surface are all highly characteristic of follicular lymphoma lymphocytes. In about one third ofthe cases, though, the proportion of cleft cells that can be recognised at light microscopical may be insufficient by itself to ascertain a diagnosis of follicular lymphoma, and electron microscopical examination provides additional morphological detail.
The membrane markers of follicular lymphoma cells and CLL lymphocytes are also characteristic (table 3) . The follicular lymphoma lymphocyte seems to be immunologically more mature than the CLL cell, as shown by a higher content of SmIg, low M-rosette formation, strong reactivity with FMC7, and the rare expression of the CD5 antigen. In addition, the membrane expression of the cALLa (CDO1) antigen is reported to be a hallmark of follicular centre cells," occurring much less often in typical CLL cells-as in the present study. The characteristic composite marker phenotype of B-CLL was not seen in any ofthe cases of follicular lymphoma studied (table 3); only two cases had high expression of CD5 and only one (case 10) with typical follicular lymphoma histology had high numbers M-rosettes and low FMC7 positivity. In our small series the incidence of SmIg with A isotype was relatively high, compared with the approximate two-to three-fold predominance of expressing cases K in most CLL series. 8 12 Whether the predominance of A-expressing clones in follicular lymphoma is another feature of immunological maturity, as suggested previously from studies of Iggene rearrangements in B cell malignancies'3 is not presently known. The ultimate diagnostic confirmation of follicular lymphoma and other follic!e centre cell types of NHL is seen in the lymph node histology. There is usually no difficulty in making these diagnoses even in predominantly diffuse small and large cell lymphoma. In this series the predominant cell was the small cleaved cell, although mixed small and large cell types were also observed. Bone marrow disease seems to be ubiquitous, and there is usually heavy infiltration with a paratrabecular and diffuse distribution.
Another B cell disorder to consider in the differential diagnosis of follicular lymphoma presenting with high white cell count is "intermediate" lymphocytic or mantle zone NHL.'4 These cases often present with splenomegaly and have a progressive course; high white cell count of >50 x I09/l has rarely been observed. In common with B-CLL, the cells of intermediate lymphoma express the p67 protein (CD5) and have variable expression of cALLa (CD10). Morphologically, the cells have a condensed nuclear chromatin with slight irregularity and indentation and are of intermediate size. The differential diagnosis from follicular lymphoma includes the morphology of the circulating cells (there are few descriptions ofcases in leukaemic phase), the membrane phenotype, and, most importantly, the lymph node histology which is predominantly diffuse or vaguely nodular with effacing of the nodal architecture.'4 None of the cases included in this report, including those with expression ofCD5, had features resembling intermediate NHL. If we consider the three main diagnostic criteria: histology of lymph nodes and bone marrow, markers and morphology, each of our 10 cases had two or three positive criteria for the diagnosis of follicular lymphoma.
The aggressive evolution of the disease and overall poor response to treatment in patients from the present series stand out as considerably different from the natural history of both typical CLL and the commoner form of follicular lymphoma with only moderately high white cell counts. In the latter two disorders the median survival has been reported to be about eight years'01 and about five years,'35 respectively, half the patients in the present study were dead within three years of diagnosis. Although the initial response to treatment was relatively good in those patients who are still alive at the time of writing, remissions were usually short and treatment for relapse was seldom effective.
Perhaps the neoplastic clone in the hyperleucocytic leukaemia form of follicular lymphoma has a higher proliferative rate than in CLL, which would account for the rapid onset of symptoms, the abrupt rise in the white cell count, and the massive organomegaly, as well as for the overall poor response to conventional chemotherapy often effective in CLL. Because of its poor prognosis, it is important that this special presentation of follicular lymphoma is correctly diagnosed, and that lymph node excision is done when the suggestive clinical, haematological, and immunological features we have described are found.
A consistent chromosome abnormality t(l4; 18) has been shown in 85% of cases of follicular lymphoma.`6
Additional abnormalities seemed to be associated with a worse prognosis. Ofinterest is the observation that a deletion 13q32 was seen in cases evolving with a leukaemic phase'6; it is likely that this type of cytogenetic information would further strengthen the characterisation of the leukaemic phase of follicular lymphoma.
